Currently predicting for Thu, 4 Jun 2026

NKTX Prediction Chart

NKTX Predictions History

Latest community submissions for NKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 11, 2024 $14.17 -3.13% $14.00 V 98.77% 2
Mar 11, 2024 $14.34 -1.96% $14.00 V 97.54% 1
Mar 11, 2024 Bullish $14.00 X 0
Mar 7, 2024 $15.27 -2.79% $14.88 V 97.37% 1
Mar 7, 2024 $15.44 -1.74% $14.88 V 96.26% 1
Mar 7, 2024 Bullish $14.88 V 0
JS JS Pro
Mar 6, 2024 $13.37 +1.13% $15.71 V 85.11% 1
AlexVel AlexVel Pro
Mar 6, 2024 $13.14 -0.61% $15.71 X 83.64% 0
Mar 4, 2024 $12.47 -2.89% $13.09 X 95.26% 0
Mar 4, 2024 $12.61 -1.81% $13.09 X 96.32% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NKARTA INC.
Nkarta
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE